Floatz logo

ip-001

Colorectal Liver Metastasis (CRLM)

Immunophotonics, Inc.Phase 2/3Active
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
95/ 100

Competitive context

33 Active assets in the Colorectal Liver Metastasis (CRLM) cohort.

Asset / SponsorPhaseRating
Eloxatin
Fudan University
Phase 4BBB
Fruquintinib
Peking University
Phase 3BBB
DEXAMETHASONE
Fudan University
Phase 3BB
Capecitabine
Jun Huang
Phase 3BB
Irinotecan
Jun Huang
Phase 3BB

View all 50 →

Same molecule, other indications

ip-001 is also rated in:

rectal cancerDormant
B
Indicative ·
57 / 100
View asset →
Colon Cancer Liver MetastasesDormant
B
Indicative ·
57 / 100
View asset →
colorectal cancerDormant
CCC
Indicative ·
52 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →